HomeCompareRKAGY vs ORCC

RKAGY vs ORCC: Dividend Comparison 2026

RKAGY yields 0.74% · ORCC yields 9.79%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ORCC wins by $1.6K in total portfolio value
10 years
RKAGY
RKAGY
● Live price
0.74%
Share price
$8.16
Annual div
$0.06
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$19.8K
Annual income
$0.07
Full RKAGY calculator →
ORCC
ORCC
● Live price
9.79%
Share price
$13.48
Annual div
$1.32
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$1.04
Full ORCC calculator →

Portfolio growth — RKAGY vs ORCC

📍 ORCC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRKAGYORCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RKAGY + ORCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RKAGY pays
ORCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RKAGY
Annual income on $10K today (after 15% tax)
$62.50/yr
After 10yr DRIP, annual income (after tax)
$0.06/yr
ORCC
Annual income on $10K today (after 15% tax)
$832.34/yr
After 10yr DRIP, annual income (after tax)
$0.88/yr
At 15% tax rate, ORCC beats the other by $0.82/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RKAGY + ORCC for your $10,000?

RKAGY: 50%ORCC: 50%
100% ORCC50/50100% RKAGY
Portfolio after 10yr
$20.6K
Annual income
$0.56/yr
Blended yield
0.00%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

RKAGY
No analyst data
Altman Z
3.0
Piotroski
4/9
ORCC
Analyst Ratings
9
Buy
4
Hold
1
Sell
Consensus: Buy
Price Target
$16.00
+18.7% upside vs current
Range: $16.00 — $16.00
Altman Z
0.5
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RKAGY buys
0
ORCC buys
0
No recent congressional trades found for RKAGY or ORCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRKAGYORCC
Forward yield0.74%9.79%
Annual dividend / share$0.06$1.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%-50%
Portfolio after 10y$19.8K$21.4K
Annual income after 10y$0.07$1.04
Total dividends collected$74.00$1.0K
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: RKAGY vs ORCC ($10,000, DRIP)

YearRKAGY PortfolioRKAGY Income/yrORCC PortfolioORCC Income/yrGap
1← crossover$10,737$36.76$11,190$489.61$453.00ORCC
2$11,507$18.45$12,229$256.01$722.00ORCC
3$12,321$9.24$13,216$130.74$895.00ORCC
4$13,189$4.62$14,207$66.02$1.0KORCC
5$14,114$2.31$15,234$33.17$1.1KORCC
6$15,103$1.16$16,317$16.62$1.2KORCC
7$16,161$0.58$17,468$8.32$1.3KORCC
8$17,293$0.29$18,695$4.16$1.4KORCC
9$18,503$0.14$20,006$2.08$1.5KORCC
10$19,799$0.07$21,407$1.04$1.6KORCC

RKAGY vs ORCC: Complete Analysis 2026

RKAGYStock

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. Its hospitals offer treatment services, including rehabilitation of cardiovascular patients, hand surgery, neurological, psychosomatic, addiction therapy facilities, ophthalmology, trauma surgery, dentistry, thoracic, pulmonary, vascular, tumors, neurological conditions, and treatment of spinal column, joints, and heart diseases. It operates eight hospitals and 5,420 beds/places at five medical sites. The company is based in Bad Neustadt an der Saale, Germany.

Full RKAGY Calculator →

ORCCBDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →
📬

Get this RKAGY vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RKAGY vs SCHDRKAGY vs JEPIRKAGY vs ORKAGY vs KORKAGY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.